We are live on
!
Find out more
CM
CM Management Portfolio holdings
AUM
$157M
1-Year Est. Return
60.08%
This Fund
S&P 500
This Quarter
Est. Return
-1.99%
1 Year Est. Return
+60.08%
3 Year Est. Return
+110.48%
5 Year Est. Return
+186.03%
10 Year Est. Return
–
AUM
$119M
AUM Growth
-$13.3M
(-10%)
Cap. Flow
-$4.3M
Cap. Flow
% of AUM
-3.61%
Top 10 Holdings %
Top 10 Hldgs %
39.21%
Holding
91
New
3
Increased
43
Reduced
6
Closed
20
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
+$1.97M |
| 2 |
Kyndryl
KD
|
+$1.35M |
| 3 |
B
Barrick Mining
B
|
+$1.18M |
| 4 |
EXE
Expand Energy Corp
EXE
|
+$1.1M |
| 5 |
Heron Therapeutics
HRTX
|
+$1.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTRA
Coterra Energy
CTRA
|
+$3.04M |
| 2 |
Kinder Morgan
KMI
|
+$1.98M |
| 3 |
Cytokinetics
CYTK
|
+$1.95M |
| 4 |
First Financial Corp
THFF
|
+$1.81M |
| 5 |
CVS Health
CVS
|
+$1.55M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 37.33% |
| 2 | Energy | 14.56% |
| 3 | Financials | 10.58% |
| 4 | Materials | 8.62% |
| 5 | Technology | 7.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
USAP
51
DELISTED
Universal Stainless & Alloy
USAP
| $781K | 0.66% |
90,000
| – | – |
|
|
SPPI
52
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $774K | 0.65% |
600,000
+450,000
| +300% | +$414K |
|
|
ARKOW
53
DELISTED
ARKO Corp Warrant
ARKOW
| $760K | 0.64% |
400,000
+100,000
| +33% | +$158K |
|
54
BioCardia
BCDA
$16.3M
| $681K | 0.57% |
21,933
| – | – |
|
55
Garrett Motion
GTX
$5.22B
| $647K | 0.54% |
90,000
| – | – |
|
56
AMCON Distributing
DIT
$66M
| $621K | 0.52% |
6,000
| – | – |
|
57
Cartesian Therapeutics
RNAC
$280M
| $615K | 0.52% |
16,667
+3,334
| +25% | +$209K |
|
|
NBSE
58
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $611K | 0.51% |
16,250
+8,750
| +117% | +$302K |
|
59
Smith Micro Software
SMSI
$15.9M
| $603K | 0.51% |
4,000
| – | – |
|
60
inTEST
INTT
$143M
| $590K | 0.5% |
55,000
+35,000
| +175% | +$383K |
|
61
Gain Therapeutics
GANX
$78.6M
| $511K | 0.43% |
125,000
+35,000
| +39% | +$146K |
|
62
Femasys
FEMY
$25M
| $509K | 0.43% |
11,250
+6,250
| +125% | +$345K |
|
|
BCEL
63
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $476K | 0.4% |
150,000
+85,000
| +131% | +$206K |
|
|
CBAY
64
DELISTED
Cymabay Therapeutics
CBAY
| $467K | 0.39% |
150,000
| – | – |
|
|
SVC
65
Service Properties Trust
SVC
$986M
| $442K | 0.37% |
10,000
+5,000
| +100% | +$218K |
|
66
Newell Brands
NWL
$2.6B
| $428K | 0.36% |
20,000
+10,000
| +100% | +$231K |
|
67
Compass Therapeutics
CMPX
$429M
| $411K | 0.35% |
+300,000
| New | +$620K |
|
68
Relmada Therapeutics
RLMD
$473M
| $405K | 0.34% |
15,000
+5,000
| +50% | +$103K |
|
69
Nektar Therapeutics
NKTR
$2.53B
| $404K | 0.34% |
5,000
+3,333
| +200% | +$493K |
|
70
Aterian
ATER
$11.2M
| $243K | 0.2% |
8,333
+2,083
| +33% | +$76.3K |
|
71
Lantern Pharma
LTRN
$24.4M
| $241K | 0.2% |
+33,765
| New | +$225K |
|
72
ACNB Corp
ACNB
$671M
| – | – |
-35,000
| Closed | -$1.09M |
|
73
Agnico Eagle Mines
AEM
$104B
| – | – |
-20,000
| Closed | -$1.06M |
|
74
Bristol-Myers Squibb
BMY
$136B
| – | – |
-15,000
| Closed | -$935K |
|
|
CTRA
75
DELISTED
Coterra Energy
CTRA
| – | – |
-160,000
| Closed | -$3.04M |
|
Similar funds
SFSG
PTFIS
AWMG
BCI
LDNAM
DFS
APW
GA
CM Management's Q1 2022 Portfolio in Review
As of Q1 2022, CM Management held 91 positions worth $119M, down 10% from $132M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
CM Management withdrew a net $4.3M in Q1 2022, closing 20 positions and reducing 6 holdings. Its most notable exit was Coterra Energy, an estimated $3.04M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 37% of assets, down from 38% a quarter earlier, followed by Energy and Financials.
Against the trend, CM Management opened a new position in Walgreens Boots Alliance worth $1.79M.
- CM Management's largest Q1 2022 buy was Walgreens Boots Alliance: 40,000 shares worth $1.79M.
- CM Management added most to Kyndryl in Q1 2022, an estimated $1.35M increase.
- CM Management's biggest Q1 2022 reduction was Cytokinetics, cutting an estimated $1.95M.
- CM Management fully exited Coterra Energy in Q1 2022, selling an estimated $3.04M.
- CM Management's ten largest holdings make up 39% of its $119M portfolio in Q1 2022.
- CM Management opened 3 new positions and closed 20 in Q1 2022.
- CM Management's portfolio value fell 10% quarter-over-quarter to $119M.
Based on CM Management's 13F filing for Q1 2022, filed 9 May 2022.